Loading clinical trials...
Loading clinical trials...
Comparison of Eleveld and Schnider Models for Target-Controlled Infusion of Propofol in Intensive Care Unit Sedation
This prospective observational study aims to compare the clinical performance of two target-controlled infusion (TCI) models, Eleveld and Schnider, for propofol sedation in mechanically ventilated intensive care unit (ICU) patients. The study evaluates sedation depth, hemodynamic stability, and recovery profiles using the Bispectral Index (BIS) and Riker Sedation-Agitation Scale. Secondary outcomes include awakening time, total propofol dose, and incidence of delirium after sedation withdrawal. The findings may help identify the most reliable pharmacokinetic model for safe and effective ICU sedation.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Hacettepe University
Ankara, Turkey (Türkiye)
Start Date
February 1, 2025
Primary Completion Date
December 1, 2025
Completion Date
January 1, 2026
Last Updated
November 20, 2025
84
ESTIMATED participants
propofol
DRUG
TCI Propofol Injection
DEVICE
Lead Sponsor
Hacettepe University
NCT07461376
NCT07269808
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions